411 related articles for article (PubMed ID: 15340086)
21. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders.
Bachinski LL; Sirito M; Böhme M; Baggerly KA; Udd B; Krahe R
Muscle Nerve; 2010 Dec; 42(6):856-63. PubMed ID: 21104860
[TBL] [Abstract][Full Text] [Related]
22. MEF2C exon α: role in gene activation and differentiation.
Infantino V; Convertini P; Menga A; Iacobazzi V
Gene; 2013 Dec; 531(2):355-62. PubMed ID: 24008018
[TBL] [Abstract][Full Text] [Related]
23. Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy.
Baruffaldi F; Montarras D; Basile V; De Feo L; Badodi S; Ganassi M; Battini R; Nicoletti C; Imbriano C; Musarò A; Molinari S
Stem Cells; 2017 Mar; 35(3):725-738. PubMed ID: 27612437
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation.
Sebastian S; Faralli H; Yao Z; Rakopoulos P; Palii C; Cao Y; Singh K; Liu QC; Chu A; Aziz A; Brand M; Tapscott SJ; Dilworth FJ
Genes Dev; 2013 Jun; 27(11):1247-59. PubMed ID: 23723416
[TBL] [Abstract][Full Text] [Related]
25. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
Grégoire S; Yang XJ
Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
[TBL] [Abstract][Full Text] [Related]
26. Expression of myocyte enhancer factor-2 and downstream genes in ground squirrel skeletal muscle during hibernation.
Tessier SN; Storey KB
Mol Cell Biochem; 2010 Nov; 344(1-2):151-62. PubMed ID: 20617369
[TBL] [Abstract][Full Text] [Related]
27. PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C.
Micheli L; Leonardi L; Conti F; Buanne P; Canu N; Caruso M; Tirone F
Mol Cell Biol; 2005 Mar; 25(6):2242-59. PubMed ID: 15743821
[TBL] [Abstract][Full Text] [Related]
28. Myocyte enhancer factor 2A is transcriptionally autoregulated.
Ramachandran B; Yu G; Li S; Zhu B; Gulick T
J Biol Chem; 2008 Apr; 283(16):10318-29. PubMed ID: 18073218
[TBL] [Abstract][Full Text] [Related]
29. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
Yang CC; Ornatsky OI; McDermott JC; Cruz TF; Prody CA
Nucleic Acids Res; 1998 Oct; 26(20):4771-7. PubMed ID: 9753748
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A.
Cox DM; Du M; Marback M; Yang EC; Chan J; Siu KW; McDermott JC
J Biol Chem; 2003 Apr; 278(17):15297-303. PubMed ID: 12586839
[TBL] [Abstract][Full Text] [Related]
31. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR.
Creemers EE; Sutherland LB; Oh J; Barbosa AC; Olson EN
Mol Cell; 2006 Jul; 23(1):83-96. PubMed ID: 16818234
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
33. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
Zang MX; Li Y; Xue LX; Jia HT; Jing H
J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
[TBL] [Abstract][Full Text] [Related]
34. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.
Quinn ZA; Yang CC; Wrana JL; McDermott JC
Nucleic Acids Res; 2001 Feb; 29(3):732-42. PubMed ID: 11160896
[TBL] [Abstract][Full Text] [Related]
35. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
[TBL] [Abstract][Full Text] [Related]
36. MyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNA.
Ichida M; Endo H; Ikeda U; Matsuda C; Ueno E; Shimada K; Kagawa Y
J Biol Chem; 1998 Apr; 273(14):8492-501. PubMed ID: 9525963
[TBL] [Abstract][Full Text] [Related]
37. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
38. Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.
Wu W; de Folter S; Shen X; Zhang W; Tao S
PLoS One; 2011 Mar; 6(3):e17334. PubMed ID: 21394201
[TBL] [Abstract][Full Text] [Related]
39. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
